🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We've successfully completed our thirteenth Qcide® harvest in Far North Queensland, refining production from #Eucalyptus cloeziana trees with a shortened harvest interval and pre-extraction treatments to improve oil extraction efficiency. Working alongside engineers from James

REMINDER | Bio-Gene CEO & MD Tim Grogan will be presenting tomorrow at the NWR Communications Virtual Healthcare Conference at 2:40 pm AEDT (20 March 2025). Register to attend the live presentation here: us02web.zoom.us/webinar/regist…. A recording will be available at the same link after the

We're pleased to provide our investor presentation for today's NWR Communications Healthcare Conference: wcsecure.weblink.com.au/pdf/BGT/029270… Shareholders, investors and interested parties are encouraged to register to attend the presentation at the following link: us02web.zoom.us/webinar/regist… A

In case you missed it – CEO & Managing Director Tim Grogan's presentation at the NWR Communications Healthcare Conference is now available to watch. 🎥 Watch the $BGT replay here: youtu.be/c_abLGOtHiY?si… NWR Communications #Agtech #ASX

CEO & Managing Director Tim Grogan recently spoke at the NWR Communications Virtual #Healthcare Conference, outlining Bio-Gene’s strategic approach to commercialisation and partnerships. By partnering with global leaders like Clarke, Envu (formerly Bayer Environmental Science), Evergreen

We’re continuing to strengthen the Qcide® seed and seedling production program in Far North Queensland, ensuring long-term scalability and supply to meet future demand. A dedicated seed production area has now been established, with careful thinning and tree management to

“We’re seeing a global shift — the era of launching new #insecticides based on synthetic chemistry is coming to an end.” In this video, CEO & MD Tim Grogan explains how Bio-Gene Technology is responding to changing regulatory, consumer and supply chain pressures by developing two

Our Quarterly Activities Report for the period ending 31 March 2025 has been released. Commenting on the Company’s progress during Q3 FY25 and to date, Managing Director & CEO, Tim Grogan said: "Bio-Gene’s focused development of Flavocide® and Qcide® has been recognised through

In a recent interview with 180 Markets, MD Tim Grogan explains the unique origins of Bio-Gene’s two active compounds Flavocide® and Qcide® and how they offer distinct, nature-based solutions for global insect control. “Qcide® is fully organic, steam-distilled from Eucalyptus

Bed bug infestations are surging globally, with some regions, including Singapore, reporting a 30–40% rise in recent months. Resistance to existing insecticides is making outbreaks harder to manage, with pest controllers reporting a 30–40% increase in infestations in some

Investor Presentation - Placement, May 2025 View the full $BGT Presentation here: wcsecure.weblink.com.au/pdf/BGT/029432… #agtech

We’ve raised $2.1M through a Placement and will launch a Share Purchase Plan for eligible shareholders on 12 May 📈 Funds will support regulatory safety studies for Flavocide® — a major step toward approval — plus Qcide scale-up and strategic projects. More:

Bugs beware! Bio-Gene secures $2.1 million to advance its insect-busting tech | $BGT Media coverage by AustralianManufacturingForum. #Agtech aumanufacturing.com.au/bugs-beware-bi…

Bio-Gene Technology Media coverage $BGT

Our Executive Director of R&D, Peter May, recently presented at the JCU AgTAC Seminar Series, outlining our work with James Cook University to support the development of Qcide® , a nature-derived insecticide produced from Eucalyptus cloeziana. Since 2018, Bio-Gene and JCU have

We've launched a Share Placement Plan for eligible shareholders, following our recent $2.1 million placement to professional investors. Shareholders on the register at 7:00pm (AEST) on 2 May 2025 can apply for up to $15,000 in new shares at $0.023 per share. For every two shares

Our Executive Director - Research & Development, Peter May, will attend the Australian Grain Storage & Protection Conference in Melbourne, 4–5 June 2025. With growing concerns around insecticide resistance threatening global food security, the event is a critical forum to

We've successfully raised $338,500 through our Share Purchase Plan (SPP).  Combined with the $2.1 million raised via placement earlier in May, total funds raised amount to $2.45 million before costs. Proceeds will support regulatory studies for Flavocide®, Qcide® scale-up,